As of 2024-12-12, the Fair Value of XSpray Pharma AB (publ) (XSPRAY.ST) is -34.74 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 44.45 SEK, the upside of XSpray Pharma AB (publ) is -178.16%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -45.77 | -52.41 | -96.70 | -131.67 | -179.67 | -101.24 |
| YoY growth | -98.16% | -14.50% | -84.50% | -36.17% | -36.45% | -53.96% |
| Market Cap (mil) | 1,650.81 |
| P/E | |
| Forward P/E |
| EPS | -6.95 |
| Avg earnings growth rate | -53.96% |
| TTM earnings | -258.05 |